SCHEIN PHARMACEUTICAL INC
10-Q, EX-27, 2000-08-04
PHARMACEUTICAL PREPARATIONS
Previous: SCHEIN PHARMACEUTICAL INC, 10-Q, 2000-08-04
Next: CFC INTERNATIONAL INC, 10-Q, 2000-08-04



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONDENSED CONSOLIDATED BALANCE SHEET AT JUNE 24, 2000 AND THE
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE
24, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-START>                             DEC-26-1999
<PERIOD-END>                               JUN-24-2000
<CASH>                                           6,463
<SECURITIES>                                         0
<RECEIVABLES>                                   76,252
<ALLOWANCES>                                   (1,759)
<INVENTORY>                                    103,516
<CURRENT-ASSETS>                               211,330
<PP&E>                                         180,549
<DEPRECIATION>                                (81,418)
<TOTAL-ASSETS>                                 386,035
<CURRENT-LIABILITIES>                          328,835
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           334
<OTHER-SE>                                      46,641
<TOTAL-LIABILITY-AND-EQUITY>                   386,035
<SALES>                                        193,075
<TOTAL-REVENUES>                               193,075
<CGS>                                          152,702
<TOTAL-COSTS>                                   53,323
<OTHER-EXPENSES>                                 (561)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,170
<INCOME-PRETAX>                               (22,559)
<INCOME-TAX>                                   (9,024)
<INCOME-CONTINUING>                           (13,535)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (13,535)
<EPS-BASIC>                                     (0.41)
<EPS-DILUTED>                                   (0.41)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission